Results 41 to 50 of about 6,779 (124)

Gastrointestinal mucormycosis-an uncommon isolated mucormycosis. [PDF]

, 1998
Background: Isolated mucormycosis of the gastrointestinal tract is uncommon, with only two case reports from India. Objectives: To study the clinicopathologic features of gastrointestinal mucormycosis in Indian patients.
Kataria, R., Acharya, S. K., Gill, S. S., Gupta, D. K., Sharma, M. C., Sahni, P., Kashyap, S.   +6 more
core   +2 more sources

Mucormycosis: A Brief Review

, 2019
Mucormycosis is an angio invasive infection that occurs due to the fungi mucorales. It is a rare disease but increasingly recognized in immunocompromised patients.
Vyshnavi Devi Janagaraj, Narasimhan Malathi, Vinithra Karthikeyan, Ramalingam Suganya   +3 more
core   +1 more source

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

, 2019
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving.
Lanternier, F., White, P.L., Patel, A., Groll, A.H., Klimko, N., Guinea, J., Pana, Z.D., Lagrou, K., Drgona, L., Sidharthan, N., Arikan-Akdagli, S., Pagano, L., Skiada, A., Arenz, D., Corzo-León, D.E., Lehrnbecher, T., Chen, SCA, Bonifaz, A., Singh, N., Dannaoui, E., Chayakulkeeree, M., Seidel, D., Colombo, A.L., Sheppard, D.C., Nucci, M., Jensen, H.E., Lewis, R.E., Vehreschild, J.J., Vehreschild, MJGT, Heussel, C.P., Seyedmousavi, S., Pasqualotto, A., Badali, H., Bretagne, S., Meletiadis, J., Ullmann, A.J., Al-Hatmi, AMS, Lass-Floerl, C., Maschmeyer, G., Alastruey-Izquierdo, A., Wahba, R., Ibrahim, A.S., Richardson, M., Hoenigl, M., Walsh, T.J., Mares, M., Steinbach, W., Ruhnke, M., Kanj, S.S., Mer, M., Chakrabarti, A., Lackner, M., Akova, M., Roilides, E., Lee, D.G., Racil, Z., Zaoutis, T., Hochhegger, B., Slavin, M., Lamoth, F., Lmimouni, B.E., Soman, R., Tan, B.H., Cornely, O.A., Sinko, J., Wiederhold, N.P., Ben-Ami, R., Oladele, R., Spellberg, B., Mellinghoff, S.C., Meis, J.F., Alanio, A., Castagnola, E., Morrissey, C.O.   +73 more
core   +1 more source

Mucormycosis [PDF]

, 2008
The zygomycoses are infections caused by fungi of the class zygomycetes, comprised of the orders Mucorales and Entomophthorales. Fungi ofthis order are causes of mucormycosis, an acute opportunistic infection occurring mostly in immunocompromised ...
S. D. Mathebula
core   +1 more source

Mixed Invasive Aspergillus–Mucorales Pulmonary Coinfection in a Diabetic Patient: An Uncommon Dual Fungal Pneumonia and Literature Review

Respirology Case Reports, Volume 14, Issue 10, October 2026.
Our case describes a rare lung co‐infection caused by Aspergillus and Mucorales in a 61‐year‐old man with uncontrolled diabetes and chronic kidney disease. The diagnosis was made by BAL PCR and biopsy. Despite antifungal treatment, the patient worsened and died.
Vinay Venugopal, Saurabh Karmakar, Abdul Raouf Wani, Akshita Gupta, Gaurav Kumar Singh, Vijay Kumar, Shubhendu Mishra, Alpana Srivastava   +7 more
wiley   +1 more source

MUCORMYCOSIS – A CASE SERIES. [PDF]

, 2012
Mucormycosis is a rare opportunistic fungal infection with a rapidly progressive and fulminantcourse with often fatal outcome. A less fulminant variety of this is the Rhino maxillary subtypewhich usually presents with palatal ulceration, facial swelling,
Gopalakrishnan, Shankaranarayanan; Kilpauk Medical College
core  

Review Article: Immune Effector Cell‐Mediated Enterocolitis Following CAR‐T Cell Therapy—Clinical Features, Pathophysiology and Management

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 8, Page 1046-1057, October 2026.
Immune effector cell‐mediated enterocolitis is an emerging complication of CAR‐T therapy. This review summarizes its epidemiology, pathophysiology, diagnosis, endoscopic and histopathologic features, and evidence‐based management, emphasizing early recognition, multidisciplinary intervention, and step‐up therapy.
John A. Damianos, Yi Lin, Zongming Eric Chen, Kenneth J. C. Lim, Navreet M. Chowla   +4 more
wiley   +1 more source

Coronavirus disease 2019-associated mucormycosis of the head-and-neck area: A new rise of dreaded black fungus in the current pandemic

Journal of the Scientific Society, 2022
Coronavirus disease 2019 (COVID-19) pandemic is currently evolving and associated with more complications with invasive fungal infection like mucormycosis.
Santosh Kumar Swain, Pragnya Paramita Jena   +1 more
doaj   +1 more source

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

ChemFoodChem, Volume 2, Issue 3, September 2026.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

MUCORMYCOSIS: AN OVERVIEW

, 2021
Mucormycosis is termed as an angio-invasive fungal infection, connected with high morbidity and mortality. An alteration in the epidemiology of mucormycosis has been discovered in recent years with the rise in frequency, newfound causative agents and ...
Surushe C., Karpe M., Kadam V.
core   +1 more source